These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 20347310

  • 1. Utility of mammaglobin and gross cystic disease fluid protein-15 (GCDFP-15) in confirming a breast origin for recurrent tumors.
    Chia SY, Thike AA, Cheok PY, Tan PH.
    Breast; 2010 Oct; 19(5):355-9. PubMed ID: 20347310
    [Abstract] [Full Text] [Related]

  • 2. Mammaglobin vs GCDFP-15: an immunohistologic validation survey for sensitivity and specificity.
    Bhargava R, Beriwal S, Dabbs DJ.
    Am J Clin Pathol; 2007 Jan; 127(1):103-13. PubMed ID: 17145637
    [Abstract] [Full Text] [Related]

  • 3. Diagnostic utility of mammaglobin and GCDFP-15 in the identification of metastatic breast carcinoma in fluid specimens.
    Yan Z, Gidley J, Horton D, Roberson J, Eltoum IE, Chhieng DC.
    Diagn Cytopathol; 2009 Jul; 37(7):475-8. PubMed ID: 19217055
    [Abstract] [Full Text] [Related]

  • 4. Co-expression and prognostic value of gross cystic disease fluid protein 15 and mammaglobin in primary breast cancer.
    Fritzsche FR, Thomas A, Winzer KJ, Beyer B, Dankof A, Bellach J, Dahl E, Dietel M, Kristiansen G.
    Histol Histopathol; 2007 Nov; 22(11):1221-30. PubMed ID: 17647195
    [Abstract] [Full Text] [Related]

  • 5. Expression of mammaglobin and gross cystic disease fluid protein-15 in breast carcinomas.
    Luo MH, Huang YH, Ni YB, Tsang JY, Chan SK, Shao MM, Tse GM.
    Hum Pathol; 2013 Jul; 44(7):1241-50. PubMed ID: 23332923
    [Abstract] [Full Text] [Related]

  • 6. Distinguishing breast carcinoma from Müllerian serous carcinoma with mammaglobin and mesothelin.
    Kanner WA, Galgano MT, Stoler MH, Mills SE, Atkins KA.
    Int J Gynecol Pathol; 2008 Oct; 27(4):491-5. PubMed ID: 18753974
    [Abstract] [Full Text] [Related]

  • 7. Comparative study of monoclonal antibody B72.3 and gross cystic disease fluid protein-15 as markers of apocrine carcinoma of the breast.
    Honma N, Takubo K, Arai T, Younes M, Kasumi F, Akiyama F, Sakamoto G.
    APMIS; 2006 Oct; 114(10):712-9. PubMed ID: 17004974
    [Abstract] [Full Text] [Related]

  • 8. Analysis of expression patterns of breast cancer-specific markers (mammaglobin and gross cystic disease fluid protein 15) in lung and pleural tumors.
    Takeda Y, Tsuta K, Shibuki Y, Hoshino T, Tochigi N, Maeshima AM, Asamura H, Sasajima Y, Ito T, Matsuno Y.
    Arch Pathol Lab Med; 2008 Feb; 132(2):239-43. PubMed ID: 18251583
    [Abstract] [Full Text] [Related]

  • 9. Diagnostic utility of mammaglobin and GCDFP-15 in the identification of primary neuroendocrine carcinomas of the breast.
    Lopez-Bonet E, Pérez-Martínez MC, Martin-Castillo B, Alonso-Ruano M, Tuca F, Oliveras-Ferraros C, Cufí S, Vazquez-Martin A, Beltràn M, Bernadó L, Menendez JA.
    Breast Cancer Res Treat; 2011 Feb; 126(1):241-5. PubMed ID: 20978935
    [No Abstract] [Full Text] [Related]

  • 10. Signet ring variant of lobular carcinoma of the breast: a clinicopathologic and immunohistochemical study.
    Raju U, Ma CK, Shaw A.
    Mod Pathol; 1993 Sep; 6(5):516-20. PubMed ID: 8248106
    [Abstract] [Full Text] [Related]

  • 11. Solid neuroendocrine carcinomas of the breast: metastases or primary tumors?
    Richter-Ehrenstein C, Arndt J, Buckendahl AC, Eucker J, Weichert W, Kasajima A, Schneider A, Noske A.
    Breast Cancer Res Treat; 2010 Nov; 124(2):413-7. PubMed ID: 20872069
    [Abstract] [Full Text] [Related]

  • 12. GATA3: a promising marker for metastatic breast carcinoma in serous effusion specimens.
    Shield PW, Papadimos DJ, Walsh MD.
    Cancer Cytopathol; 2014 Apr; 122(4):307-12. PubMed ID: 24421220
    [Abstract] [Full Text] [Related]

  • 13. Analysis of the immunohistochemical expression of mammaglobin A in primary breast carcinoma and lymph node metastasis.
    Raica M, Cîmpean AM, Meche A, Alexa A, Suciu C, Mureşan A.
    Rom J Morphol Embryol; 2009 Apr; 50(3):341-7. PubMed ID: 19690758
    [Abstract] [Full Text] [Related]

  • 14. GATA-binding protein 3, gross cystic disease fluid protein-15 and mammaglobin have distinct prognostic implications in different invasive breast carcinoma subgroups.
    Ni YB, Tsang JY, Chan SK, Tse GM.
    Histopathology; 2015 Jul; 67(1):96-105. PubMed ID: 25425335
    [Abstract] [Full Text] [Related]

  • 15. GATA3 expression in morphologic subtypes of breast carcinoma: a comparison with gross cystic disease fluid protein 15 and mammaglobin.
    Wendroth SM, Mentrikoski MJ, Wick MR.
    Ann Diagn Pathol; 2015 Feb; 19(1):6-9. PubMed ID: 25544392
    [Abstract] [Full Text] [Related]

  • 16. Young investigator challenge: The utility of GATA3 immunohistochemistry in the evaluation of metastatic breast carcinomas in malignant effusions.
    Lew M, Pang JC, Jing X, Fields KL, Roh MH.
    Cancer Cytopathol; 2015 Oct; 123(10):576-81. PubMed ID: 26465236
    [Abstract] [Full Text] [Related]

  • 17. Detection of human mammaglobin mRNA in serial peripheral blood samples from patients with non-metastatic breast cancer is not predictive of disease recurrence.
    Marques AR, Teixeira E, Diamond J, Correia H, Santos S, Neto L, Ribeiro M, Miranda A, Passos-Coelho JL.
    Breast Cancer Res Treat; 2009 Mar; 114(2):223-32. PubMed ID: 18409061
    [Abstract] [Full Text] [Related]

  • 18. Serous papillary adenocarcinoma of the female genital organs and invasive micropapillary carcinoma of the breast. Are WT1, CA125, and GCDFP-15 useful in differential diagnosis?
    Moritani S, Ichihara S, Hasegawa M, Endo T, Oiwa M, Yoshikawa K, Sato Y, Aoyama H, Hayashi T, Kushima R.
    Hum Pathol; 2008 May; 39(5):666-71. PubMed ID: 18339419
    [Abstract] [Full Text] [Related]

  • 19. Mammaglobin and CRxA-01 in pleural effusion cytology: potential utility of distinguishing metastatic breast carcinomas from other cytokeratin 7-positive/cytokeratin 20-negative carcinomas.
    Ciampa A, Fanger G, Khan A, Rock KL, Xu B.
    Cancer; 2004 Dec 25; 102(6):368-72. PubMed ID: 15558786
    [Abstract] [Full Text] [Related]

  • 20. Mammaglobin expression in primary, metastatic, and occult breast cancer.
    Watson MA, Dintzis S, Darrow CM, Voss LE, DiPersio J, Jensen R, Fleming TP.
    Cancer Res; 1999 Jul 01; 59(13):3028-31. PubMed ID: 10397237
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.